Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Post-finasteride syndrome's existence is uncertain; more research needed.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Finasteride potentially treats hair loss by reducing DHT production.

Finasteride doesn't affect erections much, but may decrease libido in men.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Finasteride effectively blocks rat enzymes, but with varying methods and strength.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

PCOS is complex, affects many, and requires informed management and lifestyle changes.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Finasteride improves hair growth in men with androgenetic alopecia.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Hair loss in men is common, treatable, but not curable.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

PRP injections effectively treat hair loss, with positive results in both monthly and every three months treatments.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Finasteride shows promise for female hair loss, but more research needed.

Rice bran extract might help prevent hair loss.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.